SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
Serious Hazards of Transfusion (SHOT) shared a post on LinkedIn:
“As Sickle Cell Awareness Month begins, SHOT acknowledges the crucial role of transfusion support for many patients living with sickle cell disease.
SHOT reports continue to highlight the importance of selecting appropriately matched blood components, maintaining accurate and accessible transfusion histories, and ensuring effective communication between clinical and laboratory teams, particularly where patients receive care across multiple organisations.
Learning from haemovigilance reports supports improvements in transfusion safety and patient outcomes.”
NHS Blood and Transplant shared a post on LinkedIn:
“Today (September 1st) marks the start of Sickle Cell Awareness Month.
Sickle cell is a genetic hereditary blood disorder that makes it harder for the red cells to move around the body and they can stick together, blocking blood vessels which can cause excruciating pain, anaemia and organ damage.
It most commonly affects people from Black African or Black Caribbean backgrounds. Many patients with sickle cell rely on regular blood transfusions every 4 to 6 weeks.
To get the best treatment, people with sickle cell who have regular transfusions need blood that’s similar to their own. This is why we are using this month to appeal for more blood donors from Black African or Black Carribbean backgrounds.
Book your next appointment now and help us to save lives.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge